Analysis of the in vitro transcriptional response of human pharyngeal epithelial cells to adherent Streptococcus pneumoniae: evidence for a distinct response to encapsulated strains.
Infection of the human host by Streptococcus pneumoniae begins with colonization of the nasopharynx, which is mediated by the adherence of bacteria to the respiratory epithelium. Several studies have indicated an important role for the pneumococcal capsule in this process. Here, we used microarrays to characterize the in vitro transcriptional response of human pharyngeal epithelial Detroit 562 cells to the adherence of serotype 2 encapsulated strain D39, serotype 19F encapsulated strain G54, serotype 4 encapsulated strain TIGR4, and their nonencapsulated derivatives (Deltacps). In total, 322 genes were found to be upregulated in response to adherent pneumococci. Twenty-two genes were commonly induced, including those encoding several cytokines (e.g., interleukin 1beta [IL-1beta] and IL-6), chemokines (e.g., IL-8 and CXCL1/2), and transcriptional regulators (e.g., FOS), consistent with an innate immune response mediated by Toll-like receptor signaling. Interestingly, 85% of genes were induced specifically by one or more encapsulated strains, suggestive of a capsule-dependent response. Importantly, purified capsular polysaccharides alone had no effect. Over a third of these loci encoded products predicted to be involved in transcriptional regulation and signal transduction, in particular mitogen-activated protein kinase signaling pathways. Real-time PCR of a subset of 10 genes confirmed the microarray data and showed a time-dependent upregulation of, especially, innate immunity genes. The downregulation of epithelial genes was most pronounced upon adherence of D39Deltacps, as 68% of the 161 genes identified were repressed only by this nonencapsulated strain. In conclusion, we identified a subset of host genes specifically induced by encapsulated strains during in vitro adherence and have demonstrated the complexity of interactions occurring during the initial stages of pneumococcal infection.
Bootsma
Hester J
HJ
Laboratory of Pediatric Infectious Diseases, Radboud University Nijmegen Medical Centre, P.O. Box 9101 (Route 224), 6500 HB Nijmegen, The Netherlands.
Egmont-Petersen
Michael
M
Hermans
Peter W M
PW
D001422:Bacterial Adhesion / Q000276:immunology*; D016667:Bacterial Capsules / Q000276:immunology*; D002460:Cell Line; D016207:Cytokines / Q000235:genetics; D004847:Epithelial Cells / Q000737:chemistry / Q000382:microbiology; D020869:Gene Expression Profiling; D005786:Gene Expression Regulation; D006801:Humans; D020411:Oligonucleotide Array Sequence Analysis; D010614:Pharynx / Q000382:microbiology*; D012333:RNA, Messenger / Q000032:analysis; D020133:Reverse Transcriptase Polymerase Chain Reaction; D015398:Signal Transduction / Q000235:genetics; D013296:Streptococcus pneumoniae / Q000276:immunology*
D016207:Cytokines; D012333:RNA, Messenger
Nat Genet. 2000 May;25(1):25-9
10802651
Infect Immun. 2006 Feb;74(2):821-9
16428724
Endocr Rev. 2001 Apr;22(2):153-83
11294822
Infect Immun. 2001 Jun;69(6):3755-61
11349040
Microb Drug Resist. 2001 Summer;7(2):99-125
11442348
Science. 2001 Jul 20;293(5529):498-506
11463916
Proc Natl Acad Sci U S A. 2002 Jan 22;99(2):972-7
11805339
Methods. 2001 Dec;25(4):402-8
11846609
Res Microbiol. 2002 May;153(4):243-7
12066896
Int J Pediatr Otorhinolaryngol. 2002 Sep 24;65(3):203-11
12242135
Infect Immun. 2003 Jan;71(1):218-25
12496169
Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):1966-71
12569171
Infect Immun. 2003 Apr;71(4):2087-94
12654830
J Biol Chem. 2003 May 2;278(18):15587-94
12594207
Infect Immun. 2003 Oct;71(10):5541-8
14500472
Cell Death Differ. 2006 May;13(5):816-25
16410796
Am J Physiol Lung Cell Mol Physiol. 2006 Jun;290(6):L1131-8
16414978
Nature. 2006 May 11;441(7090):173-8
16688168
PLoS Genet. 2006 Mar;2(3):e31
16532061
J Leukoc Biol. 2006 Aug;80(2):267-77
16731773
BMC Biol. 2006;4:15
16749930
Respir Res. 2006;7:98
16834785
J Biol Chem. 2006 Sep 1;281(35):25097-109
16787930
Infect Immun. 2006 Dec;74(12):6739-49
17000730
Infect Immun. 2007 Jan;75(1):83-90
17088346
Cell Microbiol. 2007 Mar;9(3):633-44
17004992
Nucleic Acids Res. 2004 Jan 1;32(Database issue):D277-80
14681412
Proc Natl Acad Sci U S A. 2004 Jan 6;101(1):215-20
14694198
Lancet Infect Dis. 2004 Mar;4(3):144-54
14998500
Brain. 2004 Jun;127(Pt 6):1437-45
15115715
Infect Immun. 2004 Sep;72(9):4940-7
15321985
J Infect Dis. 2004 Oct 1;190(7):1203-11
15346329
J Infect Dis. 1988 Nov;158(5):948-55
3183428
Infect Immun. 1994 Jun;62(6):2582-9
8188381
J Clin Microbiol. 1995 Oct;33(10):2759-62
8567920
Infect Immun. 1997 Aug;65(8):3255-60
9234783
Mol Microbiol. 1997 Sep;25(5):819-29
9364908
J Infect Dis. 1998 Feb;177(2):368-77
9466523
J Exp Med. 2004 Dec 6;200(11):1383-93
15583012
Infect Immun. 2005 Jan;73(1):298-307
15618166
Cell Microbiol. 2005 Feb;7(2):157-65
15659060
Proc Natl Acad Sci U S A. 2005 Mar 1;102(9):3429-34
15728393
Infect Immun. 2005 Aug;73(8):4653-67
16040978
Thromb Haemost. 2005 Aug;94(2):295-303
16113818
Cell Microbiol. 2005 Oct;7(10):1404-17
16153241
Int J Pediatr Otorhinolaryngol. 2005 Oct;69(10):1383-93
15922460
Infect Immun. 2005 Oct;73(10):6479-87
16177320
Cell Microbiol. 2005 Nov;7(11):1603-15
16207247
Eur J Immunol. 2005 Oct;35(10):2962-9
16134084
Infect Immun. 2005 Nov;73(11):7718-26
16239576
Clin Infect Dis. 2006 Feb 15;42(4):451-9
16421787
Res Microbiol. 2000 Jul-Aug;151(6):413-9
10961453